Editorial Policies

Journal of Alzheimer's Research and Therapy (JALR) upholds rigorous editorial standards to protect research integrity.

Journal of Alzheimer's Research and Therapy uses a single blind peer review process. Reviewers are aware of author identities to assess research context and related work, while author identities remain confidential to reviewers. This model supports informed evaluation while protecting reviewer independence.

Each submission is first screened for scope fit and ethical compliance, followed by expert review and an editorial decision based on reviewer feedback.

• Scientific validity and methodological rigor.
• Originality and contribution to Alzheimer's research.
• Ethical compliance and transparency of reporting.
• Clinical relevance and potential impact on patient care or policy.
• Clarity of presentation and completeness of data reporting.

JALR adheres to international publication ethics standards. Manuscripts are screened for plagiarism, data fabrication, image manipulation, and duplicate publication. Suspected misconduct is investigated by the editorial office and may lead to rejection or retraction.

Authors must provide ethics approval numbers and confirm informed consent for human studies. Animal studies must follow recognized welfare guidelines.

Reviewers are expected to provide objective, constructive feedback and to identify methodological concerns, ethical issues, or potential conflicts of interest. Confidentiality is required throughout the review process.

All listed authors must have made substantial contributions to the work and must approve the final manuscript. Author contribution statements are required to ensure transparency of roles and responsibilities.

Authors, reviewers, and editors must disclose any financial or personal relationships that could influence the research or review process. Disclosures are published with the article to support transparency.

Authors must remove direct identifiers and follow applicable privacy laws when reporting patient data. If data sharing is restricted, the manuscript must explain the limitation and provide a pathway for qualified access where possible.

JALR encourages authors to share data and code whenever possible. Data availability statements are required for all submissions. When data cannot be shared, authors must provide a clear justification and describe access conditions.

Preprints are permitted. Authors must disclose preprint postings and provide the DOI or link at submission. The published version should clearly reflect any substantive updates from the preprint.

AI tools may be used for language support, but authors remain responsible for accuracy, originality, and interpretation. Any AI assisted writing or analysis tools must be disclosed.

When errors are identified after publication, JALR will issue corrections, expressions of concern, or retractions as appropriate. This protects the scientific record and ensures that readers have access to accurate information.

Authors are kept informed of review progress and decisions through the submission system. JALR aims to provide clear timelines, detailed feedback, and consistent decision rationale to support author planning.

Authors may appeal editorial decisions by providing a clear scientific rationale. Appeals are reviewed by senior editors and may result in re evaluation if justified. Complaints are handled confidentially and in accordance with ethical guidelines.

Authors are encouraged to follow recognized reporting standards such as CONSORT, PRISMA, STROBE, and ARRIVE. Clear reporting supports reproducibility and improves peer review efficiency.

Editorial decisions are independent of sponsors, advertisers, or commercial interests. The journal protects the integrity of the review process by separating editorial activities from business functions.

JALR publishes under open access licensing to maximize readership and reuse. Authors retain copyright and grant reuse rights with proper attribution. Licensing details are provided in the copyright and license policy.

For policy questions or ethical concerns, contact [email protected]. We respond promptly to ethical queries and policy clarifications.